These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria. Feezor RJ; Oberholzer C; Baker HV; Novick D; Rubinstein M; Moldawer LL; Pribble J; Souza S; Dinarello CA; Ertel W; Oberholzer A Infect Immun; 2003 Oct; 71(10):5803-13. PubMed ID: 14500502 [TBL] [Abstract][Full Text] [Related]
5. Differential cytokine response in host defence mechanisms triggered by gram-negative and gram-positive bacteria, and the roles of gabexate mesilate, a synthetic protease inhibitor. Iwadou H; Morimoto Y; Iwagaki H; Sinoura S; Chouda Y; Kodama M; Yoshioka T; Saito S; Yagi T; Tanaka N J Int Med Res; 2002; 30(2):99-108. PubMed ID: 12025532 [TBL] [Abstract][Full Text] [Related]
6. [Pathogenic mechanisms in the development of surgical site infections]. Jovanović Z; Ilić M; Janković S Med Pregl; 2007; 60(7-8):343-50. PubMed ID: 17990800 [TBL] [Abstract][Full Text] [Related]
7. The dual role of LBP and CD14 in response to Gram-negative bacteria or Gram-negative compounds. Heumann D; Lauener R; Ryffel B J Endotoxin Res; 2003; 9(6):381-4. PubMed ID: 14733725 [TBL] [Abstract][Full Text] [Related]
9. Mast cells as critical effectors of host immune defense against Gram-negative bacteria. Matsuguchi T Curr Med Chem; 2012; 19(10):1432-42. PubMed ID: 22360480 [TBL] [Abstract][Full Text] [Related]
10. Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis? Opal SM; Cohen J Crit Care Med; 1999 Aug; 27(8):1608-16. PubMed ID: 10470773 [TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults. Sutherland AM; Walley KR; Russell JA Crit Care Med; 2005 Mar; 33(3):638-44. PubMed ID: 15753758 [TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of septic shock: implications for prevention and treatment. Calandra T J Chemother; 2001 Nov; 13 Spec No 1(1):173-80. PubMed ID: 11936363 [TBL] [Abstract][Full Text] [Related]
13. Hypothesis: combined inhibition of complement and CD14 as treatment regimen to attenuate the inflammatory response. Mollnes TE; Christiansen D; Brekke OL; Espevik T Adv Exp Med Biol; 2008; 632():253-63. PubMed ID: 19025127 [TBL] [Abstract][Full Text] [Related]
14. Mediators of systemic inflammatory response syndrome and the role of recombinant activated protein C in sepsis syndrome. Kak V Infect Dis Clin North Am; 2011 Dec; 25(4):835-50. PubMed ID: 22054759 [TBL] [Abstract][Full Text] [Related]
15. Molecular biology of endotoxin antagonism. Lazaron V; Dunn DL World J Surg; 2002 Jul; 26(7):790-8. PubMed ID: 11948366 [TBL] [Abstract][Full Text] [Related]
16. Monocytic thrombomodulin triggers LPS- and gram-negative bacteria-induced inflammatory response. Ma CY; Shi GY; Shi CS; Kao YC; Lin SW; Wu HL J Immunol; 2012 Jun; 188(12):6328-37. PubMed ID: 22573811 [TBL] [Abstract][Full Text] [Related]
17. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. Osuchowski MF; Welch K; Siddiqui J; Remick DG J Immunol; 2006 Aug; 177(3):1967-74. PubMed ID: 16849510 [TBL] [Abstract][Full Text] [Related]
18. Bride and groom in systemic inflammation--the bells ring for complement and Toll in cooperation. Barratt-Due A; Pischke SE; Brekke OL; Thorgersen EB; Nielsen EW; Espevik T; Huber-Lang M; Mollnes TE Immunobiology; 2012 Nov; 217(11):1047-56. PubMed ID: 22964230 [TBL] [Abstract][Full Text] [Related]
19. Gram-positive and gram-negative bacterial toxins in sepsis: a brief review. Ramachandran G Virulence; 2014 Jan; 5(1):213-8. PubMed ID: 24193365 [TBL] [Abstract][Full Text] [Related]
20. Cellular mechanisms in sepsis. Jean-Baptiste E J Intensive Care Med; 2007; 22(2):63-72. PubMed ID: 17456726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]